HOME >> MEDICINE >> NEWS
Spot on treatment for acne

A previously unknown side effect of an unnamed drug currently on the marketplace could be useful for treating acne, reports Chemistry & Industry, the magazine of the SCI. A UK company is about to start a Phase 1 trial with the drug involving 18 healthy human volunteers and the results are expected to be announced later this year. In an earlier Phase 1 study in nine healthy human volunteers, the treatment was seen to reduce the excretion of sebum by the skin, which is associated with acne development, by up to 70%.

The Phase I results are startlingly good, said Nigel Blackburn, director of clinical development at the company, Summit, which is organising the trial. Reducing sebum production has been the holy grail of acne treatment for 30 years, and there has been little success aside from Roaccutane which has significant side effects.

The current gold standard for acne treatment, Roaccutane can cause a wide range of side effects, including teratogenicity which leads to abonormalities in the unborn foetus of pregnant women, and has also recently been linked to depression and (inconclusively) to teenage suicides. The market for acne treatments is worth several billion dollars, and any new treatment developed without side effects could potentially reap blockbuster sales.

Although Summit has not disclosed the name of the drug now under evaluation, the company says it represents an entirely new class of compounds for treating acne. At the doses we are looking at any side effects should be mild compared with those resulting from Roaccutane treatment, Blackburn commented.

The company hopes to begin critical Phase 2 trials to assess the efficacy of the drug in acne sufferers next year. Depending on the results, the drug could either be formulated as a stand-alone topical treatment or more likely in combination with other existing treatments. The company has already been in talks with several interested companies, who are waiting
'"/>

Contact: SCI Press Office
press@soci.org
44-020-759-81548
Society of Chemical Industry
13-Aug-2007


Page: 1 2

Related medicine news :

1. New treatment boosts muscle function in myasthenia gravis
2. New treatment effective in counteracting cocaine-induced symptoms
3. UCLA researchers awarded $9M contract for study identifiying antibiotic treatment for MRSA
4. Preventive treatments in elderly people needs rethinking
5. Osteoporosis screening and treatment may be cost-effective for selected older men
6. Quality of treatment guidelines
7. Green tea holds promise as new treatment for inflammatory skin diseases
8. Many heart attack patients still not getting emergency clot-busting treatment
9. Electric fields have potential as a cancer treatment
10. New algorithm matches any tumor cells to best possible anti-cancer treatments
11. Screening for behavioral health first step to getting treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... ... October 16, 2018 , ... ... and clinical research networking-technology company founded by patient-survivors, and The Avoca Group, ... in the clinical trial execution process, today announced its mutual collaboration that ...
(Date:10/13/2018)... ... 13, 2018 , ... The National Fitness Foundation, the official ... Burley as its new Vice President of Partnerships & Marketing. , ... the mission of the President's Council by generating private sector investments and partnerships ...
(Date:10/11/2018)... ... October 11, 2018 , ... ... medical clinic of all sizes and specialties. PrognoCIS , their Health IT ... for their patients. , Greater Houston Healthconnect (GHH), the region’s health information exchange ...
(Date:10/6/2018)... ... 2018 , ... Jose Rodriguez- Feliz M.D is a board–certified ... well known for their exclusivity, and luxurious lifestyle publication is privileged to present ... to the Haute Living network. , Haute Beauty consists of a prominent ...
(Date:10/5/2018)... ... 2018 , ... The Congress of Neurological Surgeons is pleased ... which currently includes 2-D and 3-D videos. Surgical Theater and NEUROSURGERY® Publications will ... number of surgical videos submitted to the journal will be invited to be ...
Breaking Medicine News(10 mins):
(Date:10/5/2018)... MCLEAN, Va. (PRWEB) , ... October 05, 2018 ... ... pleased to announce that Lissa Goldenstein has been named Chair-Elect of the Board ... the association’s strategic initiatives. RESOLVE is dedicated to ensuring that all people challenged ...
(Date:10/3/2018)... ... 2018 , ... Friends of Sheba Medical Center, Tel HaShomer and ... on Sunday evening, October 14th, which will celebrate 70 years of saving lives at ... treated members of the Israel Defense Forces (IDF) and civilians wounded during the War ...
(Date:10/3/2018)... ... October 03, 2018 , ... Arizona Arthritis & Rheumatology ... TSI Healthcare, a national leader in the sales and support of ... selected to be the sole software and support provider for Arizona Arthritis & ...
Breaking Medicine Technology:
Cached News: